Pro-inflammatory cytokine pathways

Pro-inflammatory cytokine pathways are integrated signaling networks that mediate the body's inflammatory response to stimuli such as infection, trauma, or cellular stress (Dinarello, 2000, Chest). These pathways are triggered by the binding of specific cytokines—including Tumor Necrosis Factor-alpha (TNF-α), Interleukin-1 (IL-1), and Interleukin-6 (IL-6)—to their cognate receptors, subsequently activating downstream cascades like the NF-κB, MAPK, and JAK/STAT pathways (Zhang & An, 2007, PubMed). While these processes are vital for host defense and tissue repair, their chronic or excessive activation is a primary driver of autoimmune and inflammatory diseases such as rheumatoid arthritis and psoriasis (StatPearls, Physiology, Cytokines). Therapeutic strategies focus on disrupting these pathways at various levels, from extracellular ligand neutralization to intracellular kinase inhibition (Nature Reviews Rheumatology, Cytokine-targeting therapies). However, because these pathways are fundamental to immune surveillance, their pharmacological suppression can lead to significant side effects, most notably an increased susceptibility to opportunistic infections and potential malignancy (O'Shea et al., 2013, NEJM).

Other names

Inflammatory cytokine signalingPro-inflammatory cascadesCytokine-mediated inflammatory pathwaysPro-inflammatory cytokine network

Pharmacological modulation of these pathways involves the neutralization of circulating cytokines by monoclonal antibodies, the blockade of cell-surface receptors by antagonists, or the inhibition of intracellular signal transduction through small molecule inhibitors of kinases like Janus kinases (JAKs).